Report - 5.22 Secukinumab - PBS · Web viewThe ongoing head-to-head trial comparing secukinumab 300 mg and ustekinumab 45 mg and 90 mg (CLEAR, NCT02074982) is due for completion in July 2015

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form